Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

Recruiting

Phase 2

Yttrium-90, Capecitabine, AtezolizumabY-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

Sponsor:

Brown University

Code:

NCT06555133

Conditions

Colorectal Carcinoma Metastatic in the Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

yttrium-90 radioembolization

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-14. This information was provided to ClinicalTrials.gov by Brown University on 2025-04-09.